StageZero Life Sciences to Present at the Fall Investor Summit on September 16th-17th in New York City

TORONTO, ON / ACCESSWIRE / September 12, 2019 / StageZero Life Sciences, Ltd (TSX:SZLS) (”StageZero” or the ”Company”) will be presenting at this year’s Fall Investor Summit on September 16th-17th in New York City.

The Fall Investor Summit will take place at the Essex House, featuring 160 companies and over 1,000 institutional and retail investors.

About StageZero Life Sciences, Ltd.

StageZero Life Sciences is dedicated to the early detection of cancer and multiple disease states through whole blood. Aristotle®, our next generation test, is a panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on our proven and proprietary Sentinel Principle Technology Platform which has been validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer, with further validation currently underway. In addition to building a pipeline of products for early cancer detection, the Company operates a CAP accredited and CLIA certified reference laboratory based in Richmond, Virginia that offers the ColonSentry® test as well as licensed biomarker tests for lung, breast and prostate cancers. To learn more visit www.stagezerolifesciences.com.

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. To request complimentary investor registration: please visit our website at www.microcapconf.com

PLATINUM SPONSORS

The Money Channel
Maxim

SPONSORS

CoreIR
PCG Advisory
Irth Communications
Kei Advisors
ICR
MZ Group
Sophic Capital
Marcum
Crescendo Communications
CFO Squad
Elev8
Srax IR
Sichenzia Ross Ference
Stockloan Solutions
C6 Capital
National Securities
Artesian CPA LLC
GBA Insurance
Canalyst
OTC Markets
Sutton Funding

FOR MORE INFORMATION

Please visit: www.microcapconf.com
Or, contact Ashley Allard at ashley@microcapconf.com

SOURCE: StageZero Life Sciences, Ltd

View source version on accesswire.com:
https://www.accesswire.com/559308/StageZero-Life-Sciences-to-Present-at-the-Fall-Investor-Summit-on-September-16th-17th-in-New-York-City

Staff

Recent Posts

Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025

If you are male and in your 40's and 50's and feel your testosterone levels…

5 hours ago

The Anxiety Clinic Launches Innovative Approach to Transform Anxiety into Positive Energy

Transforming Anxiety into Positive Energy: A New Approach by The Anxiety ClinicBondi Junction, New South…

9 hours ago

Solace Psychology Announces Expanded Holiday Stress Management and Mental Health Support Services

Embracing Mental Well-Being During the Festive SeasonCarlton North, Australia--(Newsfile Corp. - December 24, 2024) -…

11 hours ago

Strong Natural Diet Pill Over the Counter for 2025 – PhenQ OTC Weight Loss Supplement

If you are researching the strongest over the counter weight loss supplements in 2025 -…

11 hours ago

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

13 hours ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

14 hours ago